AID Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-AID antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityAID
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse
Isotypen/a
Formatpeptide affinity purified
Size0.1 mg
Concentration1 mg/mL
ApplicationsELISA (EIA), Western Blot (WB), Immunocytochemistry (ICC), Immunofluorescence (IF)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAID Antibody: Activation-induced cytidine deaminase (AID) was initially discovered as a homolog of the apolipoprotein B RNA-editing cytidine deaminase 1 (APOBEC1) that showed cytidine deaminase properties in stimulated B cell lines. It is necessary for somatic hypermutation and class switch recombination in B cells, but inappropriate or dysregulated expression AID is often found in tumors and B cell neoplasms. Although it is structurally and functionally similar to the APOBEC proteins, it appears unlikely that AID deaminates dC to dU residues in HIV cDNA as does APOBEC3G.
ImmunogenImmunogen: AID antibody was raised against a peptide corresponding to 14 amino acids near the carboxy terminus of human AID. Buffer: AID Antibody is supplied in PBS containing 0.02% sodium azide.
Other Names[AID; AID; ARP2; CDA2; HIGM2; HEL-S-284; AID; Single-stranded DNA cytosine deaminase; Activation-induced cytidine deaminase; activation-induced cytidine deaminase], [AICDA; AICDA; AID; ARP2; CDA2; HIGM2; HEL-S-284; AID]
Gene, Accession #[AICDA], Gene ID: 57379, NCBI: AAM95402, UniProt: Q9GZX7
Catalog #MBS151193
Price$375
Order / More InfoAID Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.